We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
-5.29%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$293M
AUM Growth
-$63.1M
Cap. Flow
-$55.7M
Cap. Flow %
-18.99%
Top 10 Hldgs %
69.39%
Holding
39
New
2
Increased
1
Reduced
21
Closed
1

Top Buys

Rank Stock Value
1
DAR icon
Darling Ingredients
DAR
+$4.37M
2
VICR icon
Vicor
VICR
+$1.33M
3
IGMS
IGM Biosciences
IGMS
+$551K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.59M
2
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$4.49M
3
DUK icon
Duke Energy
DUK
+$4.26M
4
ABBV icon
AbbVie
ABBV
+$4.22M
5
CMS icon
CMS Energy
CMS
+$3.52M

Sector Composition

Rank Sector Weight
1 Healthcare 34.02%
2 Utilities 28.11%
3 Industrials 15.07%
4 Communication Services 6.59%
5 Financials 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBU icon
26
Caribou Biosciences
CRBU
$164M
$956K 0.33%
200,000
KOD icon
27
Kodiak Sciences
KOD
$2.67B
$851K 0.29%
473,000
MNKD icon
28
MannKind Corp
MNKD
$1.25B
$806K 0.27%
195,073
VTRS icon
29
Viatris
VTRS
$20.1B
$581K 0.2%
58,252
-1,287
-2% -$13.4K
OGN icon
30
Organon & Co
OGN
$3.55B
$541K 0.18%
31,190
-280
-0.9% -$5.84K
MASS icon
31
908 Devices
MASS
$302M
$455K 0.16%
68,286
FATE icon
32
Fate Therapeutics
FATE
$324M
$424K 0.14%
200,000
RLI icon
33
RLI Corp
RLI
$5.66B
$272K 0.09%
4,000
-800
-17% -$54K
PSNL icon
34
Personalis
PSNL
$1.61B
$182K 0.06%
150,000
WBD icon
35
Warner Bros
WBD
$67.4B
$129K 0.04%
11,851
-2,960
-20% -$36.9K
PRTK
36
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-1,556,247
Closed -$3.44M

Similar funds

Bruce & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Bruce & Co held 39 positions worth $293M, down 18% from $356M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Bruce & Co withdrew a net $55.7M in Q3 2023, closing 1 position and reducing 21 holdings. Its most notable exit was Paratek Pharmaceuticals, Inc., an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Darling Ingredients worth $3.65M.

  • Bruce & Co's largest Q3 2023 buy was Darling Ingredients: 70,000 shares worth $3.65M.
  • Bruce & Co added most to IGM Biosciences in Q3 2023, an estimated $551K increase.
  • Bruce & Co's biggest Q3 2023 reduction was Merck, cutting an estimated $8.59M.
  • Bruce & Co fully exited Paratek Pharmaceuticals, Inc. in Q3 2023, selling an estimated $3.44M.
  • Bruce & Co's ten largest holdings make up 69% of its $293M portfolio in Q3 2023.
  • Bruce & Co opened 2 new positions and closed 1 in Q3 2023.
  • Bruce & Co's portfolio value fell 18% quarter-over-quarter to $293M.

Based on Bruce & Co's 13F filing for Q3 2023, filed 13 Nov 2023.